3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Radiomics
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Bone Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Gemcitabine
109
Paclitaxel
92
Carboplatin
79
Bevacizumab
75
pembrolizumab
74
Surveys and Questionnaires
70
Docetaxel
69
Cisplatin
67
Nivolumab
48
Exercise
48
Capecitabine
48
Cyclophosphamide
47
Sorafenib
43
Fluorouracil
43
Irinotecan
42
Pemetrexed
37
Albumin-Bound Paclitaxel
35
Radiotherapy
34
Dexamethasone
34
Blood Specimen Collection
34
Oxaliplatin
31
Leucovorin
31
Erlotinib Hydrochloride
31
trametinib
30
130-nm albumin-bound paclitaxel
29
Cetuximab
28
Therapeutics
26
Ipilimumab
26
Standard of Care
25
Methods
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasms
×
Radiomics
×
Clear all
NCT03872362
2019-03-13
RMBPN
Maastricht University
Completed
800 enrolled